News

As per the terms of the agreement, Elis has gained commercialization and marketing rights for Vitaros in the Gulf Countries and part of the Middle East (including, Lebanon,

The blinded, placebo-controlled, escalating-dose will enroll 100 healthy adults 18 to 49 years old, who will be grouped into four cohorts and randomised to receive either vaccine treatment

Under the pact, IDBS will install its Bioprocess Execution System to optimize the management of process development data and drive operational excellence to Lonza customers. According to IDBS,

Almirall and Forest said that Aclidinium was well tolerated in the study and all secondary endpoints demonstrated differences vs placebo for both doses. The Phase III double-blind placebo-controlled

Health Insights’ MedicaPlus is one of the comprehensive Hospital Information Management System applications to be developed in the Middle East. Health Insights’ decision to partner with InterSystems follows

The rejection of this patent application by The Indian Patent Office was for a combination of existing drugs and techniques. Following this decision, India can now supply this

VX15/2503 is a humanized antibody that blocks the activity of semaphorin 4D (SEMA4D). Vaccinex plans to initiate a second trial of VX15/2503 for MS later this year. Vaccinex

The new patent entitled, ‘Inhibitors of Serine Protease Activity and Their Use in Methods and Compositions for Treatment of Bacterial Infections,’ covers inhibition of all forms of Bacillus

ISIS-EIF4ERx targets the gene that is responsible for the production of a protein, eIF-4E, which is over-expressed in a variety of cancers, including prostate, lung, ovarian, liver, breast,